New Interim GW Director: Dr. Bushardt is a Professor & Senior Associate Dean at the GW School of Medicine & Health Sciences. He is also the CTSI-CN Faculty Co-Lead of the Translational Workforce Development
Dr. Bushardt is a tenured educator, researcher, clinician, and administrator with experience in rural, community-based practice, and faculty service within three academic medical centers. He is professor and senior associate dean in the School of Medicine and Health Sciences at the George Washington University in Washington, D.C. with joint appointments in Physician Assistant (PA) Studies and Medicine. In his leadership role at GW, he oversees departments and centers comprising more than forty programs in the health professions and translational sciences. He also serves on the senior leadership team for the GW clinical enterprise, contributing expertise in the areas of workforce innovation, patient- and family-centered models of care, and operational excellence. He is licensed as a physician assistant and pharmacist with specialized training and experience in caring for patients with emphasis on management of chronic illness and interventions to address inappropriate polypharmacy and drug injury, and practices in primary care within the GW Department of Medicine. He regularly teaches and mentors trainees in the areas of pharmacology and clinical research. He is principal investigator for the GW Health Careers Opportunity Program, a healthcare workforce development program funded by the U.S. Health Resources and Services Administration. He is co-director of the Expansion of Practitioner Training in Substance Use Disorders, a grant project funded by the U.S. Substance Abuse and Mental Health Administration. He leads the Translational Workforce Development program in the Clinical Translational Science Institute at Children’s Network (CTSI-CN), funded by the National Institutes of Health’ National Center for Advancing Translational Science. Dr. Bushardt is a director-at-large on the board of the Physician Assistant Education Association. He is editor-in-chief emeritus for the Journal of the American Academy of Physician Assistants. He serves on the National Academy of Sciences, Engineering and Medicine’s Global Forum on Innovation in Health Professional Education. Dr. Bushardt previously served as a department chair at Wake Forest School of Medicine and associate vice president for workforce and process innovation at the Wake Forest Baptist Medical Center in Winston-Salem, N.C.
New Associate Director: Dr. Gomberg-Maitland is a Professor of Medicine and Director of the GW Advanced Pulmonary Hypertension Program. She is also the CTSI-CN Faculty Co-Lead of the Network Capacity Core, Participant Clinical Interactions.
Mardi Gomberg-Maitland, MD, MSc is a cardiologist and Professor of Medicine at the GW School of Medicine & Health Sciences. She also serves as the Medical Director of the MFA/GWUH Pulmonary Hypertension Program and has built a comprehensive management program to include outpatient and inpatient diagnosis and treatment, noninvasive and invasive testing, and state of the art pulmonary hypertension medication options.
Dr. Gomberg-Maitland earned her Bachelor’s degree from Yale, completed her medical degree at Albert Einstein College of Medicine of Yeshiva University, with a special distinction for research in cardiovascular medicine. She served her residency in internal medicine at New York Presbyterian Hospital, Weill-Cornell Medical Center and was accepted for fellowship in cardiovascular diseases at Mount Sinai Medical Center. Dr. Gomberg-Maitland was also a visiting fellow in critical care medicine at the New York Presbyterian Hospital/Weill-Cornell Medical Center. She earned a Master’s degree in clinical epidemiology from the Harvard School of Public Health. She is boarded in Internal Medicine and Cardiovascular Disease and is licensed in Washington, DC and the Commonwealth of Virginia.
Dr. Gomberg-Maitland is an expert clinician and researcher in the field of pulmonary heart disease. She has participated in dozens of multicenter, multinational research trials to explore new therapies for pulmonary hypertension. Her research focus is in understanding the epidemiology of pulmonary hypertension and development of novel therapeutics and biomarkers.
Dr. Gomberg-Maitland is internationally known for her work, has had extensive grant funding and is extensively published with over 150 articles, abstracts, reviews and chapters. She has published in peer-reviewed journals, including the Journal of the American College of Cardiology, JACC Heart Failure, Pulmonary Circulation, European Respiratory Journal, Chest, and the Journal of Heart and Lung Transplantation.